Bristol-Myers Squibb Co.'s $74 billion takeover of Celgene is in jeopardy after the former's second-largest shareholder has turned against it.
, the largest healthcare deal in history, is in jeopardy after Bristol-Myers' second-largest shareholder turned against the deal.
Wellington Management, which has about $1 trillion in client money and a 7.7% stake in Bristol-Myers, said in a"While Wellington agrees that Bristol-Myers should be active in business development that secures differentiated science and broadens the future revenue base, Wellington does not believe that the Celgene transaction is an attractive path towards accomplishing this goal," the investment firm said.
"Wellington's conclusion is based upon three tenets: 1) the transaction asks BMY shareholders to accept too much risk and the terms offer BMY shares to CELG shareholders at a price well below implied asset value; 2) execution success could be more difficult to achieve than depicted by Company management; and 3) alternative paths to create value for BMY shareholders could be more attractive.
The deal, which paid investors of the biotech giant Celgene one Bristol-Myers share and $50 cash for each Celgene share they owned, valued the New Jersey-based Celgene at about $102.43 a share — a 54% premium to its closing price the day before the merger was announced. A survey conducted by the Mizuho managing director Salim Syed shortly after the takeover was announced on January 3 found that more than 50% of the roughly 100 investors questioned said they were not happy with the deal. Wall Street analysts also voiced concerns.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Top Bristol-Myers shareholder comes out against $74 billion Celgene dealBristol-Myers Squibb Co's top shareholder Wellington Management said on Wed...
Lire la suite »
Celgene falls 8 percent after Wellington Management says it opposes Bristol-Myers acquisition
Lire la suite »
Top Bristol-Myers shareholder comes out against $74 billion Celgene dealBristol-Myers Squibb Co's top shareholder Wellington Management said on Wed...
Lire la suite »
Celgene falls 8 percent after Wellington Management says it opposes Bristol-Myers acquisition
Lire la suite »
Women won a record-breaking 15 Oscars this year, the most in Academy Awards historyWomen won a record-breaking 15 Oscars this year, the most in Academy Awards history via CNBCMakeIt
Lire la suite »
Property bust rattles Australia's record-breaking economyAs property prices rocketed toward the heady peak of Sydney's real-estate b...
Lire la suite »
U.S. banks record $59.1 billion in profits in fourth-quarter of 2018The U.S. banking sector recorded $59.1 billion in profits in the fourth quarter ...
Lire la suite »